James Lillie's most recent trade in MapLight Therapeutics Inc. was a trade of 5,393 Voting Common Stock done at an average price of $37.0 . Disclosure was reported to the exchange on July 15, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| MapLight Therapeutics Inc | James Lillie | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 36.99 per share. | 15 Jul 2026 | 5,393 | 235,098 | - | 37.0 | 199,487 | Voting Common Stock |
| MapLight Therapeutics Inc | James Lillie | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 36.45 per share. | 15 Jul 2026 | 5,009 | 230,077 | - | 36.4 | 182,578 | Voting Common Stock |
| MapLight Therapeutics Inc | James Lillie | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 37.26 per share. | 15 Jul 2026 | 3,526 | 226,551 | - | 37.3 | 131,379 | Voting Common Stock |
| MapLight Therapeutics Inc | James Lillie | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 36.00 per share. | 15 Jul 2026 | 2,238 | 240,491 | - | 36 | 80,568 | Voting Common Stock |
| MapLight Therapeutics Inc | James Lillie | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 37.90 per share. | 15 Jul 2026 | 2,077 | 224,462 | - | 37.9 | 78,718 | Voting Common Stock |
| MapLight Therapeutics Inc | James Lillie | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 38.00 per share. | 15 Jul 2026 | 12 | 226,539 | - | 38 | 456 | Voting Common Stock |
| MapLight Therapeutics Inc | James Lillie | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 37.50 per share. | 15 Jul 2026 | 12 | 235,086 | - | 37.5 | 450 | Voting Common Stock |
| Acuren Corp Ltd | James E. Lillie | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2026 | 12,500 | 12,500 | - | - | Restricted Stock Units | |
| MapLight Therapeutics Inc | James Lillie | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 28.28 per share. | 07 May 2026 | 721 | 242,729 | - | 28.3 | 20,390 | Voting Common Stock |
| MapLight Therapeutics Inc | James Lillie | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 29.13 per share. | 04 May 2026 | 16,421 | 243,450 | - | 29.1 | 478,344 | Voting Common Stock |
| MapLight Therapeutics Inc | James Lillie | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 28.12 per share. | 04 May 2026 | 10,132 | 269,224 | - | 28.1 | 284,912 | Voting Common Stock |
| MapLight Therapeutics Inc | James Lillie | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 27.50 per share. | 04 May 2026 | 9,250 | 285,907 | - | 27.5 | 254,375 | Voting Common Stock |
| MapLight Therapeutics Inc | James Lillie | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 28.04 per share. | 04 May 2026 | 8,390 | 259,871 | - | 28.0 | 235,256 | Voting Common Stock |
| MapLight Therapeutics Inc | James Lillie | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 28.37 per share. | 04 May 2026 | 5,526 | 280,381 | - | 28.4 | 156,773 | Voting Common Stock |
| MapLight Therapeutics Inc | James Lillie | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 29.00 per share. | 04 May 2026 | 963 | 268,261 | - | 29 | 27,927 | Voting Common Stock |
| MapLight Therapeutics Inc | James Lillie | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 30.08 per share. | 04 May 2026 | 705 | 279,356 | - | 30.1 | 21,206 | Voting Common Stock |
| MapLight Therapeutics Inc | James Lillie | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 29.56 per share. | 04 May 2026 | 320 | 280,061 | - | 29.6 | 9,459 | Voting Common Stock |
| MapLight Therapeutics Inc | James Lillie | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 27.49 per share. | 15 Apr 2026 | 2,097 | 295,157 | - | 27.5 | 57,647 | Voting Common Stock |
| MapLight Therapeutics Inc | James Lillie | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 26.82 per share. | 15 Apr 2026 | 1,730 | 297,940 | - | 26.8 | 46,399 | Voting Common Stock |
| MapLight Therapeutics Inc | James Lillie | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 27.01 per share. | 15 Apr 2026 | 686 | 297,254 | - | 27.0 | 18,529 | Voting Common Stock |
| MapLight Therapeutics Inc | James Lillie | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Feb 2026 | 31,395 | 31,395 | - | - | Employee Stock Option (right to buy) | |
| MapLight Therapeutics Inc | James Lillie | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Feb 2026 | 7,730 | 298,862 | - | 0 | Voting Common Stock | |
| MapLight Therapeutics Inc | James Lillie | Chief Scientific Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 17.98 per share. | 27 Jan 2026 | 45,055 | 291,132 | - | 18.0 | 810,089 | Voting Common Stock |
| Acuren Corp Ltd | Lillie E. James | Director | Other type of transaction at price $ 0.00 per share. | 31 Dec 2025 | 1,806,291 | 0 | - | 0 | Common Stock | |
| Acuren Corp Ltd | Lillie E. James | Director | Other type of transaction at price $ 0.00 per share. | 31 Dec 2025 | 1,806,291 | 1,816,291 | - | 0 | Common Stock | |
| Acuren Corp Ltd | E. Lillie James | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2025 | 60,122 | 1,806,291 | - | 0 | Common Stock | |
| MapLight Therapeutics Inc | James Lillie | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Oct 2025 | 132,023 | 132,023 | - | - | Employee Stock Option (right to buy) | |
| MapLight Therapeutics Inc | James Lillie | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Oct 2025 | 32,539 | 32,539 | - | 0 | Voting Common Stock | |
| Acuren Corp Ltd | James E. Lillie | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jul 2025 | 10,000 | 0 | - | - | Restricted Stock Units | |
| Acuren Corp Ltd | James E. Lillie | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jul 2025 | 10,000 | 10,000 | - | 0 | Common Stock | |
| Acuren Corp Ltd | James E. Lillie | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jul 2025 | 9,017 | 9,017 | - | - | Restricted Stock Units |